Skip to main content
menu

CMLT20100 / S1823 / Chunkit Fung

Research Question:
Studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers.

Basic Study Information

Purpose:
This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

Location: University of Rochester Medical Center
Study Reference #: CMLT20100

Lead Researcher (Principal Investigator)

Lead Researcher:  Chunkit Fung

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Return to Search